Stockscreener 앱 받기
2.21
4.74%
0.10
시간 외 거래:
2.10
-0.11
-4.98%
전일 마감가:
$2.11
열려 있는:
$2.1
하루 거래량:
174.82K
Relative Volume:
0.40
시가총액:
$58.24M
수익:
$18.94M
순이익/손실:
$-2.71M
주가수익비율:
-15.79
EPS:
-0.14
순현금흐름:
$-4.92M
1주 성능:
-5.56%
1개월 성능:
-36.31%
6개월 성능:
+58.99%
1년 성능:
+25.93%
1일 변동 폭
$2.07
$2.225
1주일 범위
$2.05
$2.41
52주 변동 폭
$1.18
$3.78
Icad Inc Stock (ICAD) Company Profile
명칭
Icad Inc
전화
603-882-5200
주소
98 SPIT BROOK ROAD, SUITE 100, NASHUA, NH
ICAD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ICAD
Icad Inc
|
2.21 | 58.24M | 18.94M | -2.71M | -4.92M | -0.14 |
|
ABT
Abbott Laboratories
|
132.66 | 230.08B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.52 | 140.97B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
365.29 | 139.39B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
93.28 | 119.61B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
68.39 | 40.21B | 5.72B | 4.17B | 259.90M | 6.97 |
Icad Inc Stock (ICAD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-01-18 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-04-22 | 개시 | Guggenheim | Buy |
| 2021-03-23 | 개시 | BTIG Research | Buy |
| 2021-02-26 | 개시 | Oppenheimer | Outperform |
| 2021-01-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-12-03 | 개시 | B. Riley Securities | Buy |
| 2020-02-05 | 개시 | JMP Securities | Mkt Outperform |
| 2020-01-09 | 개시 | Lake Street | Buy |
| 2008-12-09 | 재확인 | Canaccord Adams | Buy |
| 2008-08-01 | 재확인 | MDB Capital Group | Buy |
| 2008-05-14 | 재확인 | Canaccord Adams | Buy |
| 2008-02-14 | 개시 | Sun Trust Rbsn Humphrey | Buy |
| 2007-01-24 | 재확인 | Dawson James | Speculative Buy |
모두보기
Icad Inc 주식(ICAD)의 최신 뉴스
Advancing AI-Powered Breast Health Solutions to Transform Global Healthcare | Newswise - Newswise
iCAD to Report Fourth Quarter and Full Year 2024 Financial Results on March 19, 2025 - The Manila Times
Key Earnings Date: AI Cancer Detection Leader iCAD Sets Q4 2024 Results Release - StockTitan
iCAD, Inc. to Host Earnings Call - ACCESS Newswire
iCAD (ICAD) Expected to Announce Earnings on Monday - Defense World
iCAD, RamSoft Integrate to Enhance AI Breast Cancer Detection - HIT Consultant
ICAD, RamSoft Collaborate to Enhance Breast Cancer Detection -March 05, 2025 at 03:20 pm EST - Marketscreener.com
iCAD, Inc. and RamSoft® Announce Strategic Integration Partnership to Enhance AI-Powered Breast Health Solutions Across North America - Nasdaq
iCAD and RamSoft Announce Partnership to Deliver ProFound® - GlobeNewswire
Can This AI Technology Catch the 40% of Breast Cancers That Mammograms Miss? - StockTitan
Investor Network: iCAD, Inc. to Host Earnings Call - ACCESS Newswire
iCAD, Inc. (ICAD) and Koios Partner to Enhance AI-Powered Breast Cancer Detection - Insider Monkey
iCAD, Inc. and Koios Medical Announce Strategic Partnership for AI-Powered Breast Cancer Detection Solutions - Nasdaq
Koios Medical and iCAD Partner to Expand AI-Powered, Multi-Modality Breast Cancer Detection Solutions at ECR 2025 - GlobeNewswire
Can This New AI Partnership Transform Breast Cancer Detection? iCAD Teams With Koios - StockTitan
iCAD, Inc. (ICAD): A Bull Case Theory - Insider Monkey
iCAD, Inc. (ICAD) to Showcase AI-Powered Breast Health Innovations at ECR 2025 - Insider Monkey
9 AI News and Ratings on Wall Street’s Radar - Insider Monkey
iCAD To Showcase Five AI-Powered Research Presentations - GlobeNewswire
iCAD Shares Unchanged Ahead of Presentations - Baystreet.ca
Earnings call transcript: ICAD Q4 2024 shows strategic resilience By Investing.com - Investing.com Canada
Can AI Transform Breast Cancer Detection? iCAD's Revolutionary Research Answers Key Questions - StockTitan
iCAD (NASDAQ:ICAD) Shares Pass Above 200 Day Moving AverageWhat's Next? - MarketBeat
117,000 Shares in iCAD, Inc. (NASDAQ:ICAD) Acquired by Summit Trail Advisors LLC - MarketBeat
iCAD (NASDAQ:ICAD) Rating Lowered to “Sell” at StockNews.com - Defense World
iCAD (NASDAQ:ICAD) Lowered to Sell Rating by StockNews.com - MarketBeat
After Falling -15.24% During The Past Week, Should You Still Buy Oruka Therapeutics Inc (NASDAQ: ORKA)? - Marketing Sentinel
Icad Inc (NASDAQ:ICAD) Up 63.91% Since 52-Week Low; YTD Rose 78.69% – Here’s What You Need To Do - Marketing Sentinel
Now Is The Time To Build A Position In Health In Tech Inc (NASDAQ:HIT) - Marketing Sentinel
After Sinking 6.37% During Past Week, Is GRAIL Inc (NASDAQ: GRAL) Still A Buy? - Marketing Sentinel
Dominari Holdings Inc (NASDAQ: DOMH) Stock Gained 177.59% Over A Month – Any Room To Run? - Marketing Sentinel
Intelligent Bio Solutions Inc (NASDAQ: INBS): Can A Stock Be 51.43% Higher Year-To-Date And Still Be A Loser? - Marketing Sentinel
Reliance Global Group Inc (NASDAQ: RELI) Stock Dropped -28.15% Over A Month – Any Room To Run? - Marketing Sentinel
Sobr Safe Inc (NASDAQ: SOBR) Stock Has Dropped -22.04% Over The Month – Is There Room For Growth? - Marketing Sentinel
ScanTech AI Systems Inc (NASDAQ: STAI) Gain Of 9.66% Compared To 52-Week Low; YTD Fall -84.49% – What Should You Do Now? – Marketing Sentinel - Marketing Sentinel
Now Is The Time To Build A Position In SolarBank Corporation (NASDAQ:SUUN) - Marketing Sentinel
Icad Inc (ICAD) deserves closer scrutiny - US Post News
The Psychology of Icad Inc Inc. (ICAD) Price Performance: Understanding Market Sentiment - The InvestChronicle
Is Oragenics Inc (AMEX: OGEN) Stock Ready For A Higher Run In Its Share Price? - Marketing Sentinel
Why iCAD Inc (ICAD) Is Skyrocketing So Far In 2025 - Yahoo Finance
Short Interest in iCAD, Inc. (NASDAQ:ICAD) Decreases By 14.5% - MarketBeat
Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025 - Insider Monkey
Graphjet Technology (NASDAQ:GTI) Stock Plunged -64.80% So Far In 2025, What Analysts Expect Next? - Marketing Sentinel
Earnings call transcript: iCAD Q3 2024 sees revenue rise, SaaS shift - MSN
StockNews.com Downgrades iCAD (NASDAQ:ICAD) to Sell - MarketBeat
Why ICAD Stock Is Climbing Today - MSN
iCAD, Inc. Pre-Announces Estimated Q4 2024 Revenue - Defense World
iCAD stock soars to 52-week high, reaching $2.67 amid robust gains - MSN
After Leaping 46% iCAD, Inc. (NASDAQ:ICAD) Shares Are Not Flying Under The Radar - Simply Wall St
iCAD stock soars to 52-week high, reaching $2.67 amid robust gains By Investing.com - Investing.com South Africa
iCAD Shares Climb After 4Q Sales Guidance Beats Expectations - MarketWatch
Icad Inc (ICAD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.99%
0.27%
자본화:
|
볼륨(24시간):